Cargando…
Uncovering a novel mechanism whereby NK cells interfere with glioblastoma virotherapy
Despite initial promising results, the success of clinical trials testing oncolytic viruses in glioblastoma patients has been limited. Innate immunity appears to be one among several barriers against successful viral oncolysis. Recent findings suggest a mechanism by which natural killer cells limit...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654589/ https://www.ncbi.nlm.nih.gov/pubmed/23734319 http://dx.doi.org/10.4161/onci.23658 |